🏛️ Verified NIH Record • Updated 2026-04-27
Management of CSDH With or Without EMMA- a Randomized Control Trial (NCT04750200)
Management of Chronic Subdural Hematoma With or Without Embolization of Middle Meningeal Artery in Canada (EMMA-Can)- A Randomized Control Trial.
🔵 Active, Not Recruiting Observational / Diagnostic 🩺 Clinical Procedure Protocol Sponsor: University of Manitoba
🩺 Plain-English Summary (8th-Grade Level)
EMMA-Can is a prospective randomized open-label, blinded end point (PROBE) study, that will assess the recurrence risk and safety of embolization of the middle meningeal (EMMA) when added to standard of care treatment (surgical drainage) of chronic subdural hematoma (CSDH) compared to surgical treatment alone.
Who can join: Review the eligibility criteria below.
Location: University of Manitoba — Winnipeg, Manitoba
Age range: 18 Years
🧪 Interventions in This Study
- Embolization of the Middle Meningeal Artery (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Manitoba — Winnipeg, Manitoba
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Subdural Hematoma
- Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy — Valhalla, New York
- Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolization — Sioux Falls, South Dakota
- Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH) — Coral Gables, Florida
- The CHALLENGER Registry — New York, New York
- Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas — Burlington, Massachusetts
Explore by condition: All Chronic Subdural Hematoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.